0.06 - 0.07
0.06 - 0.24
1.89M / 3.59M (Avg.)
-1.60 | -0.04
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2454289.24%
10Y revenue/share CAGR above 1.5x YAL.AX's 1181.85%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
3243.04%
Positive 5Y CAGR while YAL.AX is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
66.54%
3Y revenue/share CAGR above 1.5x YAL.AX's 42.55%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
160.42%
OCF/share CAGR of 160.42% while YAL.AX is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
184.59%
Positive OCF/share growth while YAL.AX is negative. John Neff might see a comparative advantage in operational cash viability.
-41.57%
Negative 3Y OCF/share CAGR while YAL.AX stands at 59.70%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
74.81%
Below 50% of YAL.AX's 954.91%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-130.87%
Negative 5Y net income/share CAGR while YAL.AX is 150.63%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-165.21%
Negative 3Y CAGR while YAL.AX is 79.33%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-103.80%
Negative equity/share CAGR over 10 years while YAL.AX stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-6.15%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-258.04%
Negative 3Y equity/share growth while YAL.AX is at 0.76%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.